IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Biocon and Mylan to Collaborate in Generic Biologics

8:00 AM MDT | July 10, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it has signed an agreement with biotechnology firm Biocon (Bangalore, India) for an exclusive collaboration for the development, manufacturing, and commercialization of multiple, high-value generic biologic compounds for the global market. Mazumdar-Shaw: To lower healthcare costs. The generic pharmaceutical industry, which is based almost entirely on chemically synthesized drugs, is poised for change, Biocon says. Governments worldwide are trying to facilitate the entry of generic biotech or protein derived drugs, in an effort to lower...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa